Cargando…

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry

INTRODUCTION: Refractory asthma represents a significant unmet clinical need where the evidence base for the assessment and therapeutic management is limited. The British Thoracic Society (BTS) Difficult Asthma Network has established an online National Registry to standardise specialist UK difficul...

Descripción completa

Detalles Bibliográficos
Autores principales: Heaney, Liam G, Brightling, Chris E, Menzies-Gow, Andrew, Stevenson, Michael, Niven, Rob M
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975949/
https://www.ncbi.nlm.nih.gov/pubmed/20805172
http://dx.doi.org/10.1136/thx.2010.137414
_version_ 1782190968739463168
author Heaney, Liam G
Brightling, Chris E
Menzies-Gow, Andrew
Stevenson, Michael
Niven, Rob M
author_facet Heaney, Liam G
Brightling, Chris E
Menzies-Gow, Andrew
Stevenson, Michael
Niven, Rob M
author_sort Heaney, Liam G
collection PubMed
description INTRODUCTION: Refractory asthma represents a significant unmet clinical need where the evidence base for the assessment and therapeutic management is limited. The British Thoracic Society (BTS) Difficult Asthma Network has established an online National Registry to standardise specialist UK difficult asthma services and to facilitate research into the assessment and clinical management of difficult asthma. METHODS: Data from 382 well characterised patients, who fulfilled the American Thoracic Society definition for refractory asthma attending four specialist UK centres—Royal Brompton Hospital, London, Glenfield Hospital, Leicester, University Hospital of South Manchester and Belfast City Hospital—were used to compare patient demographics, disease characteristics and healthcare utilisation. RESULTS: Many demographic variables including gender, ethnicity and smoking prevalence were similar in UK centres and consistent with other published cohorts of refractory asthma. However, multiple demographic factors such as employment, family history, atopy prevalence, lung function, rates of hospital admission/unscheduled healthcare visits and medication usage were different from published data and significantly different between UK centres. General linear modelling with unscheduled healthcare visits, rescue oral steroids and hospital admissions as dependent variables all identified a significant association with clinical centre; different associations were identified when centre was not included as a factor. CONCLUSION: Whilst there are similarities in UK patients with refractory asthma consistent with other comparable published cohorts, there are also differences, which may reflect different patient populations. These differences in important population characteristics were also identified within different UK specialist centres. Pooling multicentre data on subjects with refractory asthma may miss important differences and potentially confound attempts to phenotype this population.
format Text
id pubmed-2975949
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-29759492010-11-26 Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry Heaney, Liam G Brightling, Chris E Menzies-Gow, Andrew Stevenson, Michael Niven, Rob M Thorax Asthma INTRODUCTION: Refractory asthma represents a significant unmet clinical need where the evidence base for the assessment and therapeutic management is limited. The British Thoracic Society (BTS) Difficult Asthma Network has established an online National Registry to standardise specialist UK difficult asthma services and to facilitate research into the assessment and clinical management of difficult asthma. METHODS: Data from 382 well characterised patients, who fulfilled the American Thoracic Society definition for refractory asthma attending four specialist UK centres—Royal Brompton Hospital, London, Glenfield Hospital, Leicester, University Hospital of South Manchester and Belfast City Hospital—were used to compare patient demographics, disease characteristics and healthcare utilisation. RESULTS: Many demographic variables including gender, ethnicity and smoking prevalence were similar in UK centres and consistent with other published cohorts of refractory asthma. However, multiple demographic factors such as employment, family history, atopy prevalence, lung function, rates of hospital admission/unscheduled healthcare visits and medication usage were different from published data and significantly different between UK centres. General linear modelling with unscheduled healthcare visits, rescue oral steroids and hospital admissions as dependent variables all identified a significant association with clinical centre; different associations were identified when centre was not included as a factor. CONCLUSION: Whilst there are similarities in UK patients with refractory asthma consistent with other comparable published cohorts, there are also differences, which may reflect different patient populations. These differences in important population characteristics were also identified within different UK specialist centres. Pooling multicentre data on subjects with refractory asthma may miss important differences and potentially confound attempts to phenotype this population. BMJ Group 2010-09 /pmc/articles/PMC2975949/ /pubmed/20805172 http://dx.doi.org/10.1136/thx.2010.137414 Text en © 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Asthma
Heaney, Liam G
Brightling, Chris E
Menzies-Gow, Andrew
Stevenson, Michael
Niven, Rob M
Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title_full Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title_fullStr Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title_full_unstemmed Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title_short Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
title_sort refractory asthma in the uk: cross-sectional findings from a uk multicentre registry
topic Asthma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975949/
https://www.ncbi.nlm.nih.gov/pubmed/20805172
http://dx.doi.org/10.1136/thx.2010.137414
work_keys_str_mv AT heaneyliamg refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry
AT brightlingchrise refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry
AT menziesgowandrew refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry
AT stevensonmichael refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry
AT nivenrobm refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry
AT refractoryasthmaintheukcrosssectionalfindingsfromaukmulticentreregistry